The Schall Law Firm Reminder to Allarity Therapeutics Investors

Overview

The Schall Law Firm, a national shareholder rights litigation firm, is reminding investors of a class action lawsuit against Allarity Therapeutics, Inc. (“Allarity” or “the Company”) (NASDAQ:ALLR) for violations of the Securities Exchange Act of 1934. The lawsuit covers the period between May 17, 2022, and July 19, 2024.

Investor Action

Investors who purchased Allarity Therapeutics securities during the mentioned period are urged to contact the firm before November 12, 2024.

Los Angeles, CA / ACCESSWIRE / September 21, 2024 – The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Allarity Therapeutics, Inc. (“Allarity” or “the Company”) (NASDAQ:ALLR) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company’s securities between May 17, 2022 and July 19,